Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Embedded Software Engineer | Job DetailsWould you like to help develop on-board solutions that are part of the daily lives of thousands of passengers?We are looking for an Embedded Software Engineer for Railway Systems to join